- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Mediators of Inflammation
Volume 2012 (2012), Article ID 214581, 5 pages
Lactoferrin Levels in the Gastric Tissue of Helicobacter pylori-Positive and -Negative Patients and Its Effect on Anemia
1Division of Pediatric Gastroenterology Hepatology and Nutrition, Department of Pediatrics, Cerrahpaşa Medical Faculty, İstanbul University, İstanbul 23119, Turkey
2Fırat Üniversitesi Hastanesi Çocuk Sağ. ve Hast. Anabilim Dalı Elazığ, Turkey
3Department of Medical Pathology, Cerrahpaşa Medical Faculty, İstanbul University, İstanbul 23119, Turkey
Received 12 August 2011; Accepted 10 January 2012
Academic Editor: Helieh S. Oz
Copyright © 2012 Yaşar Doğan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Aim. To determine gastric tissue lactoferrin (Lf) levels of Helicobacter pylori- (Hp-) positive and -negative patients and its effect on anemia. Methods. Cases in which initial presentation was of abdominal pain and that were Hp-positive at endoscopy were included. Hp-positive cases and -negative controls were divided into two groups. Results. The study included 64 cases (average: years, 39 male and 25 female). Lf levels were subsequently studied on 61 cases. 45 (73.8%) of these were Hp-positive, while 16 (22.2%) were Hp-negative. In Hp-positive cases, mean staining percentages and density of glands in the antral mucosa were % and , respectively. Hp-negative cases showed significantly different values of % and , respectively. Hemoglobin and serum ferritin values of Hp-positive cases were /dL and /mL, but these were comparable with Hp-negative cases (/dL and /mL). Conclusions. Tissue Lf was significantly higher in Hp-positive cases compared to Hp-negative cases, but no difference was observed between the two groups with regards to hemoglobin and ferritin level. As a result, it is difficult to say that this rise in Lf plays a role in the development of iron deficiency anemia in Hp-positive patients.
Helicobacter pylori (Hp) is an important etiologic cause of diseases such as chronic gastritis, duodenal and gastric ulcers, atrophic gastritis, intestinal metaplasia, and gastric lymphoma (Mucosa-associated lymphoid tissue, MALT lymphoma type) [1, 2]. Many studies suggest a relationship between iron deficiency anemia (IDA) and Hp infection, but it is not clear the mechanism by which this occurs [3, 4]. One of the suggested mechanisms occurs through Hp-mediated Lf increase in gastric tissue via neutrophils. Lf captures iron from transferrin. The iron, thus, bound to Lf is in turn picked up by the bacterium, by means of its outer membrane receptors, for its own growth. As H. pylori turnover is very rapid, the bacterial iron stores are rapidly lost in the stools, together with the dead bacteria. This mechanism, or at least its template, could explain why an iron supply is no longer available for hemopoiesis, which only enhances H. pylori proliferation [5, 6]. The proposed hypothesis is not able to answer why IDA does not develop in all infected subjects. It is possible that the presence of specific bacterium strains and the high needs for iron required by the host under particular conditions could both play a crucial role in the onset of IDA . Therefore, the purpose of this study is to determine the Lf levels in the gastric tissue of Hp-positive and -negative patients and whether this has an effect on anemia.
Patients over 4 years of age with recurring abdominal pain of unknown cause who subsequently underwent endoscopy at our hospital’s Pediatric Gastroenterology, Hepatology and Nutrition Department have been included in the study. Approval was obtained from the hospital’s ethical committee prior to this study. Before the patients were examined, their families were informed within the frame of the Helsinki report, and their signatures were taken on an informed consent form. Following record of age, gender, weight, height, and clinical details, all cases underwent an upper GIS endoscopy aimed at diagnosis. During the endoscopy, biopsy samples were taken from the gastric antrum for histological examination and tissue Lf measurement. A Helicobacter pylori gastritis diagnosis was only made after histological examination of biopsy samples. Blood was taken from all cases for full blood count, serum iron, iron binding capacity (IBC), total iron binding capacity (TIBC), and ferritin level. Patients with a digestive system or systemic disorder other than Hp gastritis, cases previously treated for Hp gastritis or peptic ulcer disease, and patients taking proton pump inhibitors or antibiotics were not included in the study.
Tissue Lf level was evaluated by a blinded pathology specialist, who was not informed about the patients’ clinical progress or the gastric antral immunohistochemical study results from primary antibody assays (DakoCytomation, LSAB2 System-HRP, Denmark).
Lactoferrin was quantitated immunohistochemically by two methods: in the first method, all samples were evaluated from 0% to 100% according to the staining percentage of glands in the antrum; in the second method, all samples were evaluated based on no staining (0), light (1), medium (2), or dense (3) according to stain-holding densities of glands in the antrum. Biopsy samples of cases were also grouped as no neutrophils (0), light (1), medium (2), or dense (3) according to the density of Lf-secreting neutrophils.
Data from this study were analyzed using the SPSS statistics software package. Nonparametric MannWhitney U and Chi-square tests were used to compare the data. In all tests, was taken as significant.
The study consisted of 64 patients with ages ranging between 4 and 17 years (average: years). 39 (60.9%) of the cases were male, while 25 (39.1%) were female. As a result of histological examination of the gastric antrum biopsy samples, 48 (75%) out of 64 cases were found to be Hp-positive, while 16 (25%) cases were Hp-negative. Endoscopic findings of Hp-positive and -negative cases are shown in Table 1. Antral nodularity in Hp-positive group was significantly higher compared to Hp-negative group (), (95% Confidence interval (CI) = 0.006–0.01).
The average age of positive cases was years, and the average age of negative cases was , which was statistically significant (). Positive Hp was seen in more male patients, but this difference was statistically insignificant (). (Table 2). Serum iron; IBC, TIBC, ferritin levels; full blood count and hemoglobin (Hb), hematocrit (Htc), leucocyte (WBC), thrombocyte (PLT), and erythrocyte count (RBC); average erythrocyte volume (MCV), average erythrocyte hemoglobin concentration (MCHC), erythrocyte distribution range (RDW), and average erythrocyte hemoglobin (MCH) values were also separately evaluated for Hp-positive and -negative cases, but no significant differences were observed. Results of power analyses for Mann-Whitney tests provided a wide range from very low to very high such as 0.051 for Hb, 0.386 for Htc, 0.421 for ferritin, and 0.948 for serum iron. These results can be interpreted as %39 power to detect a difference between Htc values of two groups with sample sizes of 16 and 48. (Table 3).
As three cases had insufficient tissue for assay, tissue Lf was only measured in the remaining 61 cases. 45 of these cases were Hp-positive, while 16 were Hp-negative. In Hp positive cases, staining percentages and density of glands in the antral mucosa were % and , respectively, while these figures were % and [(, CI = 0.0–0.048), (, CI = 0.0–0.048)] in Hp-negative cases. (Figures 1 and 2). The neutrophil density in the Hp-positive group was also significantly higher compared to the Hp-negative group. (, CI = 0.0–0.046) (Figure 3).
One of the most important clinical findings caused by Hp infection other than gastrointestinal diseases is anemia . There are quite a number of studies in the literature demonstrating the relationship between Hp and anemia in both adults and infants [9–12]. For example, in a study of young patients in South Korea, IDA in individuals infected with Hp was reported as 2.9 times higher compared to uninfected cases . It has been reported that this anemia did not improve despite iron treatment, but the hemoglobin, serum iron, and ferritin levels improved following treatment of Hp infection . In a random, placebo-controlled study in 43 infants and adults, hemoglobin levels were also reported to be significantly improved following Hp treatment .
In addition to studies suggesting a relationship between Hp and anemia, there are also studies suggesting the opposite. Collet et al. , in a study conducted on 1060 cases, reported that there was no significant difference between serum ferritin level and HP in both males and females. In a review of the current data, Bini  tried to analyze whether Hp was really to blame for anemia in these cases or whether it is an innocent bystander. He tried to find the answers as to why Hp causes anemia in only a small percentage of infected patients, how this organism causes anemia if at all, and whether or not there is improvement in anemia after treatment. As a result of this evaluation, it was shown that Hp positively correlated with low levels of ferritin, though this may not play a direct role. Our results were contrary to other studies that reported a relationship between Hp and IDA, as there was no significant difference between the average hemoglobin, hematocrit, serum iron, and ferritin levels of Hp-positive and Hp-negative groups (Table 3).
Despite all these results, it is still unclear with which mechanism Hp causes IDA in these cases. Mechanisms proposed include loss of blood from the digestive system, poor iron intake, iron absorption disorder, and use of iron in the reticuloendothelial system [11, 18, 19], and Hp is an etiological factor for gastric atrophy. Hypo- or achlorhydria may develop in individuals with atrophic gastritis, and iron absorption may decrease as a result . Contrary to current theory, it has been proposed that Lf secreted from Hp-activated neutrophils in the stomach transfers iron to the outer cell wall receptor of Hp and that an IDA then results [6, 7]. Though not many studies support this theory, Nakao et al.  reported that there is a significant increase in Lf in the gastric fluids and mucosal tissue samples in Hp-infected patients.
Lonnerdal and Iyer  reported that the main cause of this Lf increase in gastric tissue was the increase in the inflammatory mediator interleukin-8 causing attraction of neutrophils and monocytes which then secrete Lf. A different study by Nakao et al.  also reported a marked relationship between interleukin levels in the gastric mucosa and Lf increase.
Choe et al.  reported a study on 101 patients with unexplained epigastric pain and/or iron deficiency, which found markedly high Lf levels in the Hp-positive and anemia group, and Lf levels in the Hp-positive group were found to be significantly raised relative to the control group and anemia-only group. In the same study, control endoscopy 8 weeks after Hp treatment of 12 of the Hp-positive cases with anemia measured Lf and hemoglobin levels in the gastric tissue biopsies. They reported a decrease in tissue Lf and a marked increase in hemoglobin compared to pretreatment.
In this study, staining percentage of antral gland cells of Hp-positive cases and staining density of cells were significantly higher compared to Hp-negative cases (, ). Moreover, the percentage of stained neutrophils in Hp-positive cases was markedly higher compared to Hp-negative cases ().
The increase in Lf in Hp-positive cases agreed with previously conducted studies, but conversely, hemoglobin, hematocrit, and ferritin levels in these cases did not differ (Table 3). These results did not match the hypothesis that anemia is caused by loss of iron to Hp bacteria via Lf in the gastric tissue of Hp-positive cases.
We can conclude that the increase of Lf in the gastric tissue of Hp-positive cases is dependent upon inflammation. However, this iron does not seem to be transferred to Hp, as overall iron levels did not decrease in these patients and so we cannot say that the increase in Lf is connected with the subsequent development of anemia.
- J. Valle, M. Kekki, P. Sipponen, T. Ihamäki, and M. Siurala, “Long-term course and consequences of Helicobacter pylori gastritis: results of a 32-year follow-up study,” Scandinavian Journal of Gastroenterology, vol. 31, no. 6, pp. 546–550, 1996.
- A. C. Wotherspoon, C. Ortiz-Hidalgo, M. R. Falzon, and P. G. Isaacson, “Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma,” The Lancet, vol. 338, no. 8776, pp. 1175–1176, 1991.
- J. Carnicer, R. Badfa, and J. Argemf, “Helicobacter pylori gastritis and sideropenic refractory anemia,” Journal of Pediatric Gastroenterology and Nutrition, vol. 25, no. 4, p. 441, 1997.
- M. Marignani, S. Angeletti, C. Bordi et al., “Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection,” Scandinavian Journal of Gastroenterology, vol. 32, no. 6, pp. 617–622, 1997.
- C. Hershko, A. Lahad, and D. Kereth, “Gastropathic sideropenia,” Best Practice and Research, vol. 18, no. 2, pp. 363–380, 2005.
- A. Barabino, C. Dufour, C. E. Marino, F. Claudiani, and A. De Alessandri, “Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: further clinical evidence,” Journal of Pediatric Gastroenterology and Nutrition, vol. 28, no. 1, pp. 116–119, 1999.
- A. Barabino, “Helicobacter pylori-related iron deficiency anemia: a review,” Helicobacter, vol. 7, no. 2, pp. 71–75, 2002.
- L. E. Bravo, R. Mera, J. C. Reina et al., “Impact of Helicobacter pylori infection on growth of children: a prospective cohort study,” Journal of Pediatric Gastroenterology and Nutrition, vol. 37, no. 5, pp. 614–619, 2003.
- J. W. Choi, “Does Helicobacter pylori infection relate to iron deficiency anaemia in prepubescent children under 12 years of age?” Acta Paediatrica, vol. 92, no. 8, pp. 970–972, 2003.
- B. Annibale, M. Marignani, B. Monarca et al., “Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis,” Annals of Internal Medicine, vol. 131, no. 9, pp. 668–672, 1999.
- G. Baysoy, D. Ertem, E. Ademoǧlu, E. Kotiloǧlu, S. Keskin, and E. Pehlivanoǧlu, “Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter pylori infection,” Journal of Pediatric Gastroenterology and Nutrition, vol. 38, no. 2, pp. 146–151, 2004.
- Y. H. Choe, S. K. Kim, and Y. C. Hong, “Helicobacter pylori infection with iron deficiency anaemia and subnormal growth at puberty,” Archives of Disease in Childhood, vol. 82, no. 2, pp. 136–140, 2000.
- Y. H. Choe, S. K. Kim, and Y. C. Hong, “The relationship between Helicobacter pylori infection and iron deficiency: seroprevalence study in 937 pubescent children,” Archives of Disease in Childhood, vol. 88, no. 2, p. 178, 2003.
- S. J. Czinn, “Helicobacter pylori infection: detection, investigation, and management,” Journal of Pediatrics, vol. 146, no. 3, pp. S21–S26, 2005.
- Y. H. Choe, S. K. Kim, B. K. Son, D. H. Lee, Y. C. Hong, and S. H. Pai, “Randomized placebo-controlled trial of Helicobocter pylon eradication for iron-deficiency anemia in preadolescent children and adolescents,” Helicobacter, vol. 4, no. 2, pp. 135–139, 1999.
- J. A. Collett, M. J. Burt, C. M. A. Frampton et al., “Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies,” New Zealand Medical Journal, vol. 112, no. 1093, pp. 292–295, 1999.
- E. J. Bini, “Helicobacter pylori and iron deficiency anemia: guilty as charged?” American Journal of Medicine, vol. 111, no. 6, pp. 495–497, 2001.
- B. Annibale, G. Capurso, E. Lahner et al., “Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia,” Gut, vol. 52, no. 4, pp. 496–501, 2003.
- R. Yip, P. J. Limburg, D. A. Ahlquist et al., “Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency: role of Helicobacter pylori gastritis,” Journal of the American Medical Association, vol. 277, no. 14, pp. 1135–1139, 1997.
- B. Annibale, M. Marignani, C. Azzoni et al., “Atrophic body gastritis: distinct features associated with Helicobacter pylori infection,” Helicobacter, vol. 2, no. 2, pp. 57–64, 1997.
- K. Nakao, I. Imoto, E. C. Gabazza et al., “Gastric juice levels of Lactoferrin and Helicobacter pylori infection,” Scandinavian Journal of Gastroenterology, vol. 32, no. 6, pp. 530–534, 1997.
- B. Lonnerdal and S. Iyer, “Lactoferrin: molecular structure and biological function,” Annual Review of Nutrition, vol. 15, pp. 93–110, 1995.
- K. Nakao, I. Imoto, N. Ikemura et al., “Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation,” American Journal of Gastroenterology, vol. 92, no. 6, pp. 1005–1011, 1997.
- Y. H. Choe, Y. J. Oh, N. G. Lee et al., “Lactoferrin sequestration and its contribution to iron-deficiency anemia in Helicobacter pylori-infected gastric mucosa,” Journal of Gastroenterology and Hepatology, vol. 18, no. 8, pp. 980–985, 2003.